Arrakis Therapeutics
ID: 5832500Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients.
4
Funding Rounds
$226.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Arrakis Therapeutics has raised a total of $113m in funding over 4 rounds.
Key Insights:
- Arrakis Therapeutics Funding Round 2019: $75m
- Arrakis Therapeutics Series A round, February 2017: $38m
- Arrakis Therapeutics funding round, April 2019: $75m
- Arrakis Therapeutics funding round, February 2017: $38m
Industries
Arrakis Therapeutics is active in the following industries: